Summary
Definition
History and exam
Key diagnostic factors
- history of inciting event (e.g., body piercing, surgery, vaccination)
- slow growth/lack of spontaneous regression
- erythematous, smooth, and shiny elevated scar with overhanging edge
Other diagnostic factors
- itch or pain
Risk factors
- history of prior keloid
- local skin tension
- follicular inflammation/infection
- family history of keloid and genetic factors
- dark skin types
- hormonal status
- systemic conditions (e.g., hypertension, atopic eczema, Castleman disease)
- lifestyle factors
Diagnostic tests
1st tests to order
- clinical diagnosis
Tests to consider
- skin biopsy
Treatment algorithm
small/single keloid
large/bulky/multiple keloids
Contributors
Authors
Ioannis Goutos, FRCSEd(Plast)
Consultant Plastic Surgeon
Director of Academic Plastic Surgery Programmes
Queen Mary University of London
London
UK
Disclosures
IG is an author of a number of references cited in this topic.
Richard Shaffer, MRCP, FRCR
Consultant Clinical Oncologist
GenesisCare
Cromwell Hospital
London
UK
Disclosures
RS wrote the radiotherapy section of this topic. At the time of writing, he had received funds as a consultant as clinical lead for GenesisCare for skin and benign radiotherapy and as medical director for XStrahl, which designs and manufactures radiotherapy machines that can be used to treat keloid scars. RS has spoken at educational events on radiotherapy for keloid scarring and other benign and malignant conditions and has a working relationship with plastic surgeons who refer patients for radiotherapy for keloid scarring.Since contributing to the topic, RS has declared that he treats patients with radiotherapy for keloid scars in the private sector for GenesisCare and has received consulting fees from GenesisCare. He is also reimbursed for being a medical director and a shareholder and board member of Xstrahl Limited. He is board member and president of International Organisation for Radiotherapy for Benign Conditions (a community interest company), and has given webinars on the topic of radiotherapy for keloid scars for them. He is director and chief medical officer of Theralife, a company formed to treat patients with radiotherapy for non-cancer conditions. He works clinically with Ioannis Goutos for the benefit of patients with keloid scars. RS will not make further contributions to this topic.
Acknowledgements
Mr Ioannis Goutos and Dr Richard Shaffer would like to gratefully acknowledge Professor Andrew Burd, and Dr Lin Huang, previous contributors to this topic.
Declarações
AB and LH are authors of a number of references cited in this topic.
Revisores
Edward E. Tredget, MD, MSc, FRCSC
Director
Firefighters' Burn Treatment Unit and Plastic Surgery Wound Healing Research Laboratory
Professor
Department of Surgery
University of Alberta
Edmonton
Alberta
Canada
Declarações
EET declares that he has no competing interests.
Boni E. Elewski, MD
Professor and Chair of Dermatology
University of Alabama
Birmingham
AL
Declarações
BEE declares that she has no competing interests for this topic.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg. 2022 Jan 1;149(1):79e-94e.Texto completo Resumo
Ogawa R, Akita S, Akaishi S, et al. Diagnosis and treatment of keloids and hypertrophic scars - Japan Scar Workshop consensus document 2018. Burns Trauma. 2019;7:39. Resumo
Gold MH, Berman B, Clementoni MT, et al. Updated international clinical recommendations on scar management: part 1 - evaluating the evidence. Dermatol Surg. 2014 Aug;40(8):817-24. Resumo
Royal College of Radiologists. Recommendations for using radiotherapy for benign disease in the UK. 2023 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Hypertrophic scar
- Dermatofibrosarcoma protuberans
- Dermatofibroma
Mais Diagnósticos diferenciaisDiretrizes
- Recommendations for using radiotherapy for benign disease in the UK: keloid scarring
- S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids)
Mais Diretrizes
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal